Over the past five years, we have found year-over-year growth in nearly every important measure of technology transfer success.
In 2017, we launched a record number of startup companies, filed more patents and signed more licensing deals than ever before, and significantly increased the amount of research funding brought in under the MN-IP program.
|New US patent filings*||148||138||146||202||232|
|Current revenue-generating agreements||331||429||544||528||545|
|Gross revenues (in millions)||$39.5||$27.4||$20.2||$46.9||$22.6|
|Outgoing Material Transfer Agreements||281||288||297||273||233|
*Includes both US and foreign patent filings for FY2015–16; only includes US filings before FY2015
†Includes express licenses with revenue greater than $1,000 starting in FY2014; FY2015 data includes 94 licenses for the FAST technology, which is licensed to U startup FastBridge Learning
The Milken Institute's "Best Universities for Technology Transfer" report, released in April 2017, ranked the Office for Technology Commercialization sixth among US public research institutions and second in the Big Ten.
A Nature Biotechnology report of US tech transfer offices in 2013 ranked OTC fifth overall in life sciences tech transfer and gave the office high rankings in individual areas like licensing income, patents awarded and startups launched.
Annual Research Reports
Download our 2017 Annual Report on Technology Commercialization.
Learn more about the University's research enterprise as a whole.